Robert C. Seeger

33.7k citations

220 papers · 23.6k indexed · 6 hit papers · h-index 83

Impact in

Neurology top 0.01%
- Neuroblastoma Research and Treatments
Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism

Papers in

Neurology 169
- Neuroblastoma Research and Treatments 169
Cancer Research 57
- Cancer, Hypoxia, and Metabolism 48

Co-authors: Garrett M. Brodeur Katherine K. Matthay C. Patrick Reynolds Hiroyuki Shimada Daniel O. Stram Robert B. Gerbing J. Michael Bishop Harold Varmus
Journals: Journal of Clinical Oncology (26 papers)Cancer (13 papers)The Journal of Immunology (9 papers)Cancer Research (9 papers)Clinical Cancer Research (8 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Robert C. Seeger

219 papers receiving 23.0k citations

Hit Papers

6 papers align trajectories log scale

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma 2010 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 New England Journal of Medicine
2009 Journal of Clinical Oncology
1999 New England Journal of Medicine
1988 Journal of Clinical Oncology
1985 New England Journal of Medicine
1984 Science

Peers

Countries citing papers authored by Robert C. Seeger

Since Specialization

Citations

This map shows the geographic impact of Robert C. Seeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Seeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Seeger more than expected).

Fields of papers citing papers by Robert C. Seeger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Seeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Seeger. The network helps show where Robert C. Seeger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert C. Seeger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert C. Seeger Line = papers co-authored together Robert C. Seeger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Expression of neuroblastoma‐related genes in bone marrow at end of high‐risk neuroblastoma therapy Pediatric Blood & Cancer ·Shahab Asgharzadeh, Araz Marachelian, Judith G. Villablanca, Joke Struyf, Rebekah Kennedy, Richard Sposto, Arlene Naranjo, Sheena C. Tenney, Alice L. Yu, M. Fevzi Özkaynak, Paul M. Sondel, Julie R. Park, Robert C. Seeger	2022	3
2	Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma Genome Research ·Gonzalo López, Karina L. Conkrite, 直樹黒山, Komal S. Rathi, Apexa Modi, Zalman Vaksman, Abilkair Shashauov, 剛一松村, Gladiar Ayu Pawintri, Jun S. Wei, Malcolm A. Smith, Shahab Asgharzadeh, Robert C. Seeger, Javed Khan, Jaime Guidry Auvil, Daniela S. Gerhard, John M. Maris, Sharon J. Diskin	2020	14
3	Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice Journal for ImmunoTherapy of Cancer ·Michael J. Zobel, Igbineweka Paul Osa, Hongwei Wu, Jianping Sun, Danny Lascano, Jemily Malvar, Larry Wang, Michael A. Sheard, Robert C. Seeger, Eugene S. Kim	2020	13
4	Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells Clinical Cancer Research ·Hongwei Wu, Michael A. Sheard, Jemily Malvar, G. Esteban Fernández, Yves A. DeClerck, Laurence Blavier, Hiroyuki Shimada, Charles P. Theuer, Richard Sposto, Robert C. Seeger	2019	57
5	Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN -Not-Amplified Human Neuroblastoma Clinical Cancer Research ·Jun S. Wei, Igor B. Kuznetsov, Shile Zhang, Young Song, Shahab Asgharzadeh, Sivasish Sindiri, Xinyu Wen, Rajesh Patidar, 奚建平, Ashley Walton, Jaime M. Guidry Auvil, Daniela S. Gerhard, 足立秀明, Daniel Catchpoole, Stephen M. Hewitt, Paul M. Sondel, Robert C. Seeger, John M. Maris, Javed Khan	2018	76
6	Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma Clinical Cancer Research ·Akanni Fayçal, Jeremy R. Jackson, Grace E. Asuelime, Hongwei Wu, Jianping Sun, Zesheng Wan, Jemily Malvar, Michael A. Sheard, Larry Wang, Robert C. Seeger, Eugene S. Kim	2018	48
7	Natural Killer–Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms Cancer Research ·Paolo Neviani, Petra M. Wise, Mariam Murtadha, George R. Kreisel, Chunhua Wu, Ambrose Jong, Robert C. Seeger, Muller Fabbri	2018	268
8	Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells Cancer Research ·Lucia Borriello, Rie Nakata, Michael A. Sheard, G. Esteban Fernández, Richard Sposto, Jemily Malvar, Laurence Blavier, Hiroyuki Shimada, Shahab Asgharzadeh, Robert C. Seeger, Yves A. DeClerck	2017	146
9	TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells Clinical Cancer Research ·Hung C. Tran, Zesheng Wan, Michael A. Sheard, Jianping Sun, Jeremy R. Jackson, Jemily Malvar, Yibing Xu, Larry Wang, Richard Sposto, Eugene S. Kim, Shahab Asgharzadeh, Robert C. Seeger	2016	106
10	CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus Cancer Research ·Mike R. Russell, Nicol L. Davidson, Derek A. Oldridge, Juan R. Alvarez‐Dominguez, Lee McDaniel, Maura Diamond, Chun-qing Hu, Pichai Raman, Yimei Li, Jun S. Wei, Shile Zhang, Louisa Paraschopoulou, Robert C. Seeger, Shahab Asgharzadeh, Javed Khan, Sharon J. Diskin, John M. Maris, Kristina A. Cole	2015	120
11	Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma Cancer Research ·Tasnim Ara, Rie Nakata, Michael A. Sheard, Hiroyuki Shimada, Ralf Buettner, Susan Groshen, Lingyun Ji, Hua Yu, Richard Jove, Robert C. Seeger, Yves A. DeClerck	2013	105
12	Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy Clinical Cancer Research ·Yin Liu, Flávio Pereira, Michael A. Sheard, Richard Sposto, Srinivas S. Somanchi, Laurence J.N. Cooper, Dean A. Lee, Robert C. Seeger	2013	85
13	Molecular Characterization of the Pediatric Preclinical Testing Panel Clinical Cancer Research ·Geoffrey Neale, Xiaoping Su, Christopher L. Morton, Doris A. Phelps, Richard Görlick, Richard B. Lock, C. Patrick Reynolds, John M. Maris, Henry S. Friedman, Jeffrey S. Dome, Joseph D. Khoury, Timothy J. Triche, Robert C. Seeger, Richard J. Gilbertson, Javed Khan, Malcolm A. Smith, Peter J. Houghton	2008	95
14	Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells Cancer Research ·Tasnim Ara, Liping Song, Hiroyuki Shimada, Nino Keshelava, Heidi V. Russell, Leonid S. Metelitsa, Susan Groshen, Robert C. Seeger, Yves A. DeClerck	2008	145
15	The role of paracrine IL-6 and IL-10 in neuroblastoma progression (49.9) The Journal of Immunology ·Liping Song, Tasnim Ara, C. Tagoe, Zhongbin Deng, Shahab Asgharzadeh, Lingyun Ji, Richard Sposto, Yves A. DeClerck, Robert C. Seeger, Leonid S. Metelitsa	2007	1
16	The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma Cancer Research ·Xao X. Tang, Huaqing Zhao, Azim El-Gholmi A, David Y. Kim, Sakeenah L. Hicks, Susan L. Cohn, Nai‐Kong V. Cheung, Robert C. Seeger, Audrey E. Evans, Naohiko Ikegaki	2006	69
17	Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells The Journal of Immunology ·Leonid S. Metelitsa, Olga V. Naidenko, Anita Kant, Hongwei Wu, Matthew J. Loza, B Perussia, Mitchell Kronenberg, Robert C. Seeger	2001	293
18	Increase of Ceramide and Induction of Mixed Apoptosis/Necrosis by N-(4-Hydroxyphenyl)- retinamide in Neuroblastoma Cell Lines JNCI Journal of the National Cancer Institute ·Britta Maurer, Leonid S. Metelitsa, Robert C. Seeger, Myles C. Cabot, C. Patrick Reynolds	1999	246
19	Metastatic Sites in Stage IV and IVS Neuroblastoma Correlate With Age, Tumor Biology, and Survival Journal of Pediatric Hematology/Oncology ·Steven G. DuBois, З. Аликулов, John N. Lukens, Garrett M. Brodeur, Robert C. Seeger, James B. Atkinson, Gerald M. Haase, Charles T. Black, Carlos A. Pérez, Hiroyuki Shimada, Robert B. Gerbing, Daniel O. Stram, Katherine K. Matthay	1999	314
20	Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Robert C. Seeger, Sylvia A. Rayner, A.M. Saba, Helen Chung, Walter E. Laug, Harry B. Neustein, William F. Benedict	1977	206

About Robert C. Seeger

Robert C. Seeger is a scholar working on Neurology, Cancer Research, Immunology, Oncology and Molecular Biology, having authored 220 papers that have together received 23.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (169 papers), Cancer therapeutics and mechanisms (56 papers), Cancer, Hypoxia, and Metabolism (48 papers), Neuroendocrine Tumor Research Advances (26 papers), Lung Cancer Research Studies (25 papers), Immune Cell Function and Interaction (18 papers), Glioma Diagnosis and Treatment (11 papers) and Virus-based gene therapy research (11 papers). The work is most often cited by research in Neurology (15.5k citations), Cancer Research (6.5k citations), Oncology (5.4k citations), Immunology (3.8k citations) and Molecular Biology (12.2k citations). Robert C. Seeger has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Garrett M. Brodeur, Katherine K. Matthay, C. Patrick Reynolds, Hiroyuki Shimada, Daniel O. Stram, Robert B. Gerbing, J. Michael Bishop, Harold Varmus, Manfred Schwab and Judith G. Villablanca. Their work appears in journals such as Journal of Clinical Oncology, Cancer, The Journal of Immunology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact